12 февраля
Suzhou-based BrightGene Bio-Medical Technology said in a statement filed to the Shanghai Stock Exchange on Tuesday night that it has developed the technology to synthesize the active pharmaceutical ingredients of remdesivir, Gilead’s drug that is a leading candidate to treat the highly-infectious virus that’s killed more than 1,000 people. The drug isn’t licensed or approved anywhere in the world yet.
While BrightGene said that it intends to license the drug from Gilead, its move to start manufacturing at this early stage is highly unusual and a potential infringement of the American company’s intellectual property. It comes a week after Chinese researchers filed an application to patent the drug to treat the new coronavirus, a bid that would give China sway over the global use of the therapy to fight the outbreak.
https://time.com/5782633/covid-19-drug-remdesivir-china/(за ссылку спасибо
vagonsky)24 марта
проращивать бамбук номер раз
"Ааааа, МарьСанна, у вас конспирология неправильная, в Китае никто не выздоравливает, да нету и не может быть у них никакого лекарства, они методику подсчета поменяли, поэтому графики вообще не про это, и так-то китайцы никогда ни у кого ничего не воровали, а если и да, то сразу же про это всем покаянно рассказывали, вы чоу вапще, как не научная работница, чесслово!"
16 апреля
Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.
https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/
https://www.cnbc.com/2020/04/16/gilead-stock-surges-after-report-says-coronavirus-drug-trial-shows-encouraging-early-results.html
https://www.newsweek.com/remdesivir-shows-promise-coronavirus-treatment-nearly-all-patients-trial-released-within-week-1498429